Skip to main content

and
  1. Article

    Open Access

    Correction: Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study

    Taro Shibuki, Mitsuhito Sasaki, Shota Yamaguchi, Kanae Inoue in Radiation Oncology (2023)

  2. Article

    Open Access

    Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study

    Patients with unresectable pancreatic cancer (PC) sometimes experience gastrointestinal bleeding (GIB) due to tumor invasion of the gastrointestinal tract (tumor bleeding); no standard treatment has been estab...

    Taro Shibuki, Mitsuhito Sasaki, Shota Yamaguchi, Kanae Inoue in Radiation Oncology (2023)

  3. Article

    Open Access

    Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)

    No reliable nomogram has been developed until date for predicting the survival in patients with unresectable pancreatic cancer undergoing treatment with gemcitabine plus nab–paclitaxel (GnP) or FOLFIRINOX.

    Taro Shibuki, Toshihiko Mizuta, Mototsugu Shimokawa, Futa Koga, Yujiro Ueda in BMC Cancer (2022)